Skip to Content

Tag: KabaFusion


News

In brief: KabaFusion gets new investor, Philips closes recall portal, ABN set to expire

February 4, 2026HME News Staff

LEXINGTON, Mass. – KabaFusion has announced that Novo Holdings has exited its investment and Nautic Partners has completed its growth investment in the company.  KabaFusion says its clinician-led management team remains a significant investor and will continue to lead the company.  “We are thrilled to partner with Nautic, whose deep health care expertise and collaborative approach will help accelerate...

Advance Beneficiary Notice (ABN), Home Infusion Therapy, KabaFusion, Philips rec


Read Full Articlered right arrow icon

Dr. Masood

Specialty Providers

KabaFusion to accelerate growth with investment from Nautic Partners 

February 3, 2026HME News Staff

LEXINGTON, Mass. – KabaFusion has announced that Novo Holdings has exited its investment in the company and Nautic Partners has completed its growth investment in the company.  KabaFusion says its clinician-led management team remains a significant investor and will continue to lead the company.  “We are thrilled to partner with Nautic, whose deep health care expertise and collaborative approach will...

Home Infusion, Investor, KabaFusion, Mergers & Acquisitions (M&A), Nautic Partners, Private Equity


Read Full Articlered right arrow icon

KabaFusion, Tennr strengthen referral management process

Also Noted

KabaFusion, Tennr strengthen referral management process

September 11, 2025HME News Staff

NEW YORK – KabaFusion and Tennr have announced a strategic partnership that they say will further streamline care coordination, drive operational efficiencies and improve patient outcomes through the use of artificial intelligence (AI). The partnership will leverage Tennr’s advanced automation and data-driven insights to strengthen KabaFusion’s referral management processes, eliminating delays in patient onboarding and enhancing patient experience, the companies say. "Our North...

KabaFusion, Tennr


Read Full Articlered right arrow icon

News

In brief: O&P finalists, KabaFusion deal, Apple update

August 20, 2025HME News Staff

WATERLOO, Iowa – The Orthotic and Prosthetic Group of America (OPGA) has announced the finalists for the 2025 O&P Woman of the Year Award. They are:  Fanny Schultea, MS, MSEd, CPO, LP, FAAOP(D), executive director, The Orthotics and Prosthetics Foundation for Education and Research;  Lesleigh Sisson, CFO, CFm, vice president & general manager, O&P Insight;  Arlene Gillis, founder and president, International Institute of Orthotics and Prosthetics;...

Apple, Henry Schein, Inc. 5000, KabaFusion, Orthotic & Prosthetic Group of America (OPGA), Ottobock, Prochant


Read Full Articlered right arrow icon

Also Noted

KabaFusion inks agreement with Memorial Hermann

August 19, 2025HME News Staff

HOUSTON – Memorial Hermann Health System has established a services agreement with KabaFusion to provide home infusion therapy for patients with chronic conditions and for those who need intravenous immunoglobulin (IVIG) treatment. Memorial Hermann currently provides short-term home infusion therapy services. KabaFusion will help Memorial Hermann Home Infusion Pharmacy expand their services and continuity of care to patients with chronic conditions in need of treatments over a longer...

Home Infusion Therapy, KabaFusion, Memorial Hermann Health System


Read Full Articlered right arrow icon

News

In brief: KabaFusion expands footprint, CGM reduces hospitalizations, Apnimed shares positive results 

May 21, 2025HME News Staff

LEXINGTON, Mass. – KabaFusion has closed on the acquisition of six locations from Coram that will serve as pharmacies and ambulatory infusion suites.    The transaction will expand KabaFusion’s ability to serve a growing number of patients nationwide and strengthen its commitment to deliver high-quality patient care across a broad range of therapies, the company says.  “Our expansion will enable KabaFusion to serve a greater number of patients with superior...

Abbott, Apnimed, Continuous Glucose Monitor (CGM), KabaFusion, Mergers & Acquisitions (M&A)


Read Full Articlered right arrow icon

Dr. Masood

Specialty Providers

KabaFusion expands footprint 

May 20, 2025HME News Staff

LEXINGTON, Mass. – KabaFusion has closed on the acquisition of six locations from Coram that will serve as pharmacies and ambulatory infusion suites.    The transaction will expand KabaFusion’s ability to serve a growing number of patients nationwide and strengthen its commitment to deliver high-quality patient care across a broad range of therapies, the company says.  “Our expansion will enable KabaFusion to serve a greater number of patients with superior...

Home Infusion, KabaFusion


Read Full Articlered right arrow icon

Dr. Masood

Also Noted

Inovalon gets tapped by KabaFusion 

September 19, 2023HME News Staff

BOWIE, Md., and CERRITOS, Calif. – Inovalon has announced an agreement with KabaFusion to provide care capabilities and drive operational efficiencies across the company’s nationwide home and specialty infusion network. KabaFusion will use Inovalon’s ScriptMed Infusion pharmacy management software to streamline and automate operations within a single, end-to-end platform, allowing it to focus on delivering care. “Our core strategy is providing superior patient-centric care...

Home Infusion, Inovalon, KabaFusion


Read Full Articlered right arrow icon

News

In brief: GAO denies protest, OM reports growth, Numotion launches website

August 4, 2023HME News Staff

WASHINGTON – The Government Accountability Office has denied a protest by B&B Medical Services of six contracts for in-home oxygen and ventilator services awarded by the Department of Veterans Affairs to Apria Healthcare.  B&B argued that the VA’s solicitation did not properly reflect its requirements, the agency failed to consider a corporate transaction relevant to its evaluation of the awardee's responsibility and technical capability, Apria misrepresented the availability...

Apria, KabaFusion, Numotion, Owens & Minor, Philips, Rehab Medical, Soleo Health


Read Full Articlered right arrow icon

Also Noted

KabaFusion signs deals with UCB

August 3, 2023HME News Staff

CERRITOS, Calif. – KabaFusion has been selected by UCB as a limited distribution partner to provide RYSTIGGO (rozanolixizumab-noli) for the treatment of generalized myasthenia gravis in certain adult patients. “KabaFusion is proud to be a leader in home infusion and providing access to patients with new drugs that will improve their quality of life,” said Dr. Sohail Masood, founder and CEO. “We have a well-established history of successfully managing patients with myasthenia...

KabaFusion


Read Full Articlered right arrow icon